Követés
niamh keane
niamh keane
Ismeretlen szervezet
E-mail megerősítve itt: nd.edu.au
Cím
Hivatkozott rá
Hivatkozott rá
Év
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy
P Price, N Mathiot, R Krueger, S Stone, NM Keane, MA French
Journal of Clinical Virology 22 (3), 279-287, 2001
1592001
Levels of IL‐6 and soluble IL‐6 receptor are increased in HIV patients with a history of immune restoration disease after HAART
SF Stone, P Price, NM Keane, RJ Murray, MA French
HIV medicine 3 (1), 21-27, 2002
1312002
MHC haplotypes affect the expression of opportunistic infections in HIV patients
P Price, NM Keane, SF Stone, KYM Cheong, MA French
Human immunology 62 (2), 157-164, 2001
912001
Abacavir-reactive memory T cells are present in drug naive individuals
A Lucas, M Lucas, A Strhyn, NM Keane, E McKinnon, R Pavlos, ...
PloS one 10 (2), e0117160, 2015
902015
Association of increased hepatitis C virus (HCV)–specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral …
SF Stone, S Lee, NM Keane, P Price, MA French
The Journal of infectious diseases 186 (10), 1498-1502, 2002
752002
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity
NM Keane, RK Pavlos, E McKinnon, A Lucas, C Rive, CC Blyth, D Dunn, ...
Aids 28 (13), 1891-1901, 2014
662014
Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5Δ32 allele
L Gray, MJ Churchill, N Keane, J Sterjovski, AM Ellett, DFJ Purcell, ...
Journal of virology 80 (7), 3684-3691, 2006
612006
An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active …
NM Keane, P Price, S Lee, SF Stone, MA French
Clinical & Experimental Immunology 126 (1), 111-116, 2001
602001
HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes
C Bronke, CAM Almeida, E McKinnon, SG Roberts, NM Keane, A Chopra, ...
Aids 27 (6), 899-905, 2013
512013
Restoration of CD4 T‐cell responses to cytomegalovirus is short‐lived in severely immunodeficient HIV‐infected patients responding to highly active antiretroviral therapy
NM Keane, P Price, S Lee, CA Almeida, SF Stone, I James, MA French
HIV medicine 5 (6), 407-414, 2004
452004
High‐avidity, high‐IFNγ‐producing CD8 T‐cell responses following immune selection during HIV‐1 infection
NM Keane, SG Roberts, CAM Almeida, T Krishnan, A Chopra, E Demaine, ...
Immunology and cell biology 90 (2), 224-234, 2012
442012
Susceptibility to opportunistic infections in HIV‐infected patients with increased CD4 T‐cell counts on antiretroviral therapy may be predicted by markers of dysfunctional …
MA French, NM Keane, EJ McKinnon, S Phung, P Price
Hiv Medicine 8 (3), 148-155, 2007
432007
Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy
NM Keane, P Price, SF Stone, M John, RJ Murray, MA French
AIDS research and human retroviruses 16 (18), 1991-1996, 2000
402000
Interferon-Gamma Responses to Candida Recover Slowly or Remain Low in Immunodeficient HIV Patients Responding to ART
K Burgess, P Price, IR James, SF Stone, NM Keane, AYF Lim, ...
Journal of Clinical Immunology 26, 160-167, 2006
342006
Translation of HLA–HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against nef and HLA-adapted variant epitopes
CAM Almeida, C Bronke, SG Roberts, E McKinnon, NM Keane, A Chopra, ...
The Journal of Immunology 187 (5), 2502-2513, 2011
312011
Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses
CAM Almeida, SG Roberts, R Laird, E McKinnon, I Ahmed, K Pfafferott, ...
Journal of immunological methods 344 (1), 1-5, 2009
292009
Immunological markers predicting outcome in patients with hepatitis C treated with interferon‐α and ribavirin
S Lee, GC MacQuillan, NM Keane, J Flexman, GP Jeffrey, MAH French, ...
Immunology and cell biology 80 (4), 391-397, 2002
242002
A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy
P Price, NM Keane, S Lee, AFY Lim, EJ McKinnon, MA French
Immunology 119 (1), 74-82, 2006
202006
Brief Report: CXCR4 or CCR5 Tropism of Human Immunodeficiency Virus Type 1 Isolates Does Not Determine the Immunological Milieu in Patients Responding to …
P Price, N Keane, L Gray, S Lee, PR Gorry, MA French
Viral immunology 19 (4), 734-740, 2006
152006
Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction
E Phillips, A Rauch, D Nolan, A Martin, C Almeida, S Knowles, N Shear, ...
4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 2007
122007
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20